Clozapine-Induced Refractory Colonic Pseudo-Obstruction
- PMID: 38435172
- PMCID: PMC10907970
- DOI: 10.7759/cureus.53377
Clozapine-Induced Refractory Colonic Pseudo-Obstruction
Abstract
The management of treatment-resistant schizophrenia (TRS) is challenging as the medications involved, often atypical antipsychotics, have a host of associated adverse effects. While complications such as agranulocytosis are well established and necessitate close hematological monitoring, the gastrointestinal effects of particular atypical antipsychotics, such as clozapine, are recognized to a lesser extent. The following case of TRS leading to chronic treatment-resistant pseudo-obstruction, eventually requiring total colectomy, highlights the considerable sequelae of clozapine on the gastrointestinal tract. Beyond the effects of severe constipation, the possible implications of ischemic colitis, stercoral perforation, and intraabdominal sepsis warrant a degree of caution when prescribing such medication. This study sheds light on the importance of monitoring bowel motility when administering antipsychotics, particularly clozapine, to avoid these deleterious consequences.
Keywords: clozapine; colectomy; colonic pseudo-obstruction; pseudo-obstruction; refractory pseudo-obstruction.
Copyright © 2024, Siriwardena et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Clozapine induced gastrointestinal hypomotility: a potentially life threatening adverse event. a review of the literature. West S, Rowbotham D, Xiong G, Kenedi C. Gen Hosp Psychiatry. 2017;46:32–37. - PubMed
Publication types
LinkOut - more resources
Full Text Sources